Medical/Pharmaceuticals
Alma, a Sisram Medical Company, Announces the Launch of Alma Veil™ for the U.S. Market
HONG KONG and CHICAGO, July 25, 2023 /PRNewswire/ -- Alma, a global leader in the energy-based medical and aesthetic solutions industry, proudly announces the commercial availability of Alma Veil™. This advanced, dual-wavelength vascular laser workstation establishes a new standard in excellence ...
2023-07-25 22:10
3617
Fapon Launches the Most Efficient Chemiluminescence Immunoassay Analyzer to Date with Throughput of 900 T/h
ANAHEIM, Calif., July 25, 2023 /PRNewswire/ -- Fapon, a global leading life sciences company, has announced the launch of its latest chemiluminescence immunoassay system Shine i8000/9000 to global markets at the 2023 AACC exhibition. The high-speed and fully automated analyzer has an ultra-high ...
2023-07-25 20:07
2607
RemeGen's Telitacicept Shows Significant Promise in Phase II Trial for Primary Sjogren's Syndrome: Findings Published in Prestigious Rheumatology Journal
YANTAI, China, July 25, 2023 /PRNewswire/ -- RemeGen Co., Ltd.
2023-07-25 16:00
2810
Duopharma Biotech Applauded by Frost & Sullivan for Providing Innovative Healthcare Solutions in the Malaysian Market
Duopharma Biotech is a worldwide pioneer in the research and development of halal pharmaceuticals. SAN ANTONIO, July 25, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the Malaysian halal pharmaceutical industry and, based on its findings, recognizesDuopharma Biotech Berhad (Duopharma...
2023-07-25 14:00
2244
Clinical Results of ASC22 (Envafolimab) in Combination with Chidamide for Functional Cure of HIV Infection Presented at the 12th IAS Conference on HIV Science
HANGZHOU and SHAOXING, China, July 25, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that Shanghai Public Health Clinical Center presented clinical results of ASC22 (Envafolimab) in combination with Chidamide for functional cure of human immunodeficiency virus...
2023-07-25 08:10
3811
Fapon to Showcase Innovative Diagnostic and Biopharma Solutions at 2023 AACC Expo
ANAHEIM, Calif., July 24, 2023 /PRNewswire/ -- Fapon, a leading life science company, will showcase its latest innovations in in-vitro diagnostic and biopharma solutions at the 2023 American Association of Clinical Chemistry (AACC) Scientific Meeting and Clinical Lab Expo fromJuly 25 to 27. At t...
2023-07-24 21:58
2688
Biocon Biologics Announces Positive CHMP Opinion for YESAFILI®, Biosimilar Aflibercept
BRIDGEWATER, N.J. and BENGALURU, India, July 24, 2023 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion r...
2023-07-24 18:30
2385
Apollo leads India's Solid Multi-Organ Transplantation with over 23000 transplants, establishes global leadership
Apollo performs the highest number of solid organ transplants in the world per year NEW DELHI, July 24, 2023 /PRNewswire/ -- Apollo, the world's largest vertically integrated healthcare provider, has achieved a momentous feat by completing 23,000 transplants. The Apollo Transplant Program stands...
2023-07-24 14:30
2464
Project Matty: Revolutionizing Care for Children with Autism and ADHD Through AI
SINGAPORE, July 24, 2023 /PRNewswire/ -- Project Matty, a pioneering digital health solution, has been launched by a dedicated mother of an ADHD-diagnosed child and Dr.Pamela Lim, a clinical psychology doctor. Both inspired by their personal experiences and united by their commitment to improve t...
2023-07-24 12:11
4543
BGI Genomics Global Cervical Cancer Survey Finds Young Women Have Higher Vaccination Rates but 43.5 percent Put off by Pap Smears
* Vaccination and Screening Form a Virtuous Cycle to Combat Cervical Cancer HONG KONG, July 24, 2023 /PRNewswire/ -- To further inform action to combat cervical cancer, the fourth most common cancer among women globally, BGI Genomics released its State of Cervical Cancer Awareness Report today....
2023-07-24 10:30
3728
ConcertAI's TeraRecon Expands Relationship with Change Healthcare for Advanced Visualization Offering in Australia
The expanded agreement allows providers to locally acquire TeraRecon's solutions CAMBRIDGE, Mass., July 24, 2023 /PRNewswire/ -- Advanced visualization and AI leader TeraRecon, a ConcertAI company, is excited to announce an expansion of its reseller and service agreement inAustralia with Change H...
2023-07-24 04:30
2815
BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference
SUZHOU, China, July 22, 2023 /PRNewswire/ -- Last month, the American Society
for Artificial Internal Organs (ASAIO) 68th Annual Meeting
2023-07-22 18:17
7387
Menarini Group Receives Positive CHMP Opinion Recommending EC Approval of ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation
* Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more than 147,000 breast cancer patients inEurope die annually from the disease² * If approved by the European Commission, ORSERDU would be the first an...
2023-07-21 23:44
7047
Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA
SAN DIEGO, July 21, 2023 /PRNewswire/ -- Invivoscribe is excited to announce that the LeukoStrat® CDx FLT3 Mutation Assay has been approved by the U.S. Food and Drug Administration (FDA) to aid in the selection of patients with newly diagnosedFLT3-ITD positive acute myeloid leukemia (AML) who may...
2023-07-21 18:00
4313
Saphnelo now available in Malaysia as an add-on treatment for adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE)
KUALA LUMPUR, Malaysia, July 21, 2023 /PRNewswire/ -- AstraZeneca's Saphnelo ( anifrolumab) has now become available as add-on treatment for adult patients in Malaysia with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE) following insufficient response to sta...
2023-07-21 10:00
3077
Lynk Pharmaceuticals Announces First Atopic Dermatitis Patient Dosed with LNK01004 in Phase Ib Clinical Study
HANGZHOU, China, July 21, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has dosed the first patient with atopic dermatitis in a Phase Ib clinical trial of its innovative drug LNK0100...
2023-07-21 08:00
4694
ADVANCEMENTS IN TREATMENT, DIAGNOSIS AND RISK REDUCTION STRATEGIES HIGHLIGHTED AT ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE
AMSTERDAM, July 20, 2023 /PRNewswire/ -- New research reported at the Alzheimer's Association International Conference® (AAIC®) 2023 covered the breadth of Alzheimer's disease and dementia research, including advancements in treatment, early and accurate diagnosis, and our understanding of risk f...
2023-07-20 21:01
4478
Viva Biotech's Portfolio Company Riparian Pharmaceuticals Announces Exclusive License Agreement and Research Agreement with Pfizer for Novel Cardiovascular Programs
WATERTOWN, Mass., July 20, 2023 /PRNewswire/ -- Riparian Pharmaceuticals, a Viva Biotech portfolio company, is a biotechnology company focused on discovering novel therapeutics for cardiovascular diseases. Riparian today announced it has entered into an exclusive license agreement and research a...
2023-07-20 19:15
3418
PolyU awarded RGC Strategic Topics Grant to address societal needs in mental healthcare
HONG KONG, July 20, 2023 /PRNewswire/ -- The Hong Kong Polytechnic University (PolyU) has received funding support from the Strategic Topics Grant (STG) 2023/24 of the Research Grants Council (RGC) for a health technology project aimed at promoting a new paradigm shift with creation of an integra...
2023-07-20 19:07
2852
SayHeart: The AI Powerhouse Decoding Health Complexity
KUALA LUMPUR, Malaysia and SINGAPORE, July 20, 2023 /PRNewswire/ -- SayHeart, an inventive start-up, is set to redefine the healthcare industry with its AI-powered technology that simplifies convoluted health data into comprehensible narratives. Employing Generative AI, SayHeart has devised an...
2023-07-20 19:03
2979
Week's Top Stories
Most Reposted
Agoda and Emerging Travel Group Enter Strategic Partnership
[Picked up by 295 media titles]
2026-10-15 16:00Food & Hospitality Asia 2027 Redefining Excellence: The Premier Platform for Food & Beverage and Hospitality Innovation
[Picked up by 284 media titles]
2026-10-15 10:00Leading Asian DMC Discova to Attend ITB Asia 2026
[Picked up by 282 media titles]
2026-10-15 12:59
SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 282 media titles]
2026-10-19 13:18
Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
[Picked up by 272 media titles]
2026-10-21 15:00
Most Read
Sonilo Raises $11M to Build the AI-Native Audio Stack for Video
2026-10-15 00:00
29152
Agoda and Emerging Travel Group Enter Strategic Partnership
2026-10-15 16:00
18894